GM14080
LCL from B-Lymphocyte
Description:
SPINA BIFIDA
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases |
Class |
Disorders of the Nervous System |
Biopsy Source
|
Peripheral vein
|
Cell Type
|
B-Lymphocyte
|
Tissue Type
|
Blood
|
Transformant
|
Epstein-Barr Virus
|
Sample Source
|
LCL from B-Lymphocyte
|
Race
|
White
|
Relation to Proband
|
proband
|
Confirmation
|
Clinical summary/Case history
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase, Glucose-6-Phosphate Dehydrogenase, and Lactate Dehydrogenase Isoenzyme Electrophoresis |
|
Remarks |
Lumbosacral myelomeningocele; similarly affected twin sister |
dbSNP |
dbSNP ID: 17677 |
NCBI GTR |
182940 NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO; NTD |
OMIM |
182940 NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO; NTD |
Omim Description |
ANENCEPHALY, INCLUDED |
|
CAUDAL REGRESSION SYNDROME, INCLUDEDSACRAL AGENESIS, INCLUDED |
|
NEURAL TUBE CLOSURE DEFECTS, INCLUDED |
|
SPINA BIFIDA |
|
SPINA BIFIDA APERTA, INCLUDED |
|
SPINA BIFIDA CYSTICA, INCLUDED |
|
SPINA BIFIDA OCCULTA, INCLUDED |
|
SPINAL DYSRAPHIA, INCLUDED |
|
T/t LOCUS, POSSIBLE EQUIVALENT OF |
Split Ratio |
1:3 |
Temperature |
37 C |
Percent CO2 |
5% |
Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not Inactivated |
Substrate |
None specified |
Subcultivation Method |
dilution - add fresh medium |
Supplement |
- |
|
|